Filing Flows › Phathom Pharmaceuticals (PHAT) › Recalls, complaints & regulation
Phathom Pharmaceuticals (PHAT): clinical trials
Phathom Pharmaceuticals (PHAT) beyond its filings: 3 active clinical trials.
Phathom Pharmaceuticals' latest quarter
Phathom Pharmaceuticals, Q3 2026: revenue $84.7M (+71% year over year), operating margin -0.1%, net loss $13.9M, operating cash flow $1.8M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Phathom Pharmaceuticals have?
3 active studies on ClinicalTrials.gov, 1 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.